Acute Kidney Injury News and Research

RSS
Acute kidney injury (AKI) involves sudden damage to the kidneys or decrease in renal function that occurs over a few hours or days. The severity of the condition can vary from a minor loss of kidney function to kidney failure.
New Johns Hopkins-led research suggests risk factors for developing acute kidney injury

New Johns Hopkins-led research suggests risk factors for developing acute kidney injury

Six winners share £2 million to develop cutting-edge technology to prevent kidney disease

Six winners share £2 million to develop cutting-edge technology to prevent kidney disease

DURECT initiates DUR-928 multi-dose Phase 1 clinical trial for NAFLD, NASH and AKI

DURECT initiates DUR-928 multi-dose Phase 1 clinical trial for NAFLD, NASH and AKI

Cardiovascular researchers identify MG53 protein necessary for repairing injured kidney cells

Cardiovascular researchers identify MG53 protein necessary for repairing injured kidney cells

Novel device improves in-hospital safety outcomes, cognitive scores at discharge

Novel device improves in-hospital safety outcomes, cognitive scores at discharge

Astute Medical hails launch of collaborative global initiative to prevent deaths from AKI by 2025

Astute Medical hails launch of collaborative global initiative to prevent deaths from AKI by 2025

Study: Remote ischemic preconditioning not effective in improving heart bypass outcomes

Study: Remote ischemic preconditioning not effective in improving heart bypass outcomes

Medical experts aim to offer lifesaving treatments to eliminate preventable deaths from AKI by 2025

Medical experts aim to offer lifesaving treatments to eliminate preventable deaths from AKI by 2025

New global study on Acute Kidney Injury (AKI) shows the way to eliminating preventable deaths by 2025 – early detection and management are key

New global study on Acute Kidney Injury (AKI) shows the way to eliminating preventable deaths by 2025 – early detection and management are key

New medical device could revolutionise kidney disease care in the UK

New medical device could revolutionise kidney disease care in the UK

Astute Medical previews upcoming AKI & CRRT 2015 conference to be held in San Diego

Astute Medical previews upcoming AKI & CRRT 2015 conference to be held in San Diego

Urinary levels of novel biomarkers linked to adverse long-term outcomes in AKI patients

Urinary levels of novel biomarkers linked to adverse long-term outcomes in AKI patients

Certain patients with type 2 diabetes, renal impairment discouraged from taking metformin

Certain patients with type 2 diabetes, renal impairment discouraged from taking metformin

Ortho-Clinical Diagnostics announces availability of NEPHROCHECK Test System for AKI patients

Ortho-Clinical Diagnostics announces availability of NEPHROCHECK Test System for AKI patients

UL professor awarded HRB grant to improve understanding of Acute Kidney Injury

UL professor awarded HRB grant to improve understanding of Acute Kidney Injury

Astute Medical to get $30 million from CRG to support commercialization of NephroCheck Test System

Astute Medical to get $30 million from CRG to support commercialization of NephroCheck Test System

Experts to share innovative approaches to improve kidney health at ASN Kidney Week 2014

Experts to share innovative approaches to improve kidney health at ASN Kidney Week 2014

New iodine-based contrast material enhances CT images to safely use in most patients

New iodine-based contrast material enhances CT images to safely use in most patients

Canada funds 22 inventive ideas for improving health in low-resource countries

Canada funds 22 inventive ideas for improving health in low-resource countries

Astute Medical, OCD partner to expand access to new acute kidney injury test

Astute Medical, OCD partner to expand access to new acute kidney injury test

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.